Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) Other Operating Expenses (2016 - 2025)

Orthopediatrics has reported Other Operating Expenses over the past 10 years, most recently at $20.8 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $20.8 million for Q4 2025, up 11.54% from a year ago — trailing twelve months through Dec 2025 was $80.4 million (up 21.54% YoY), and the annual figure for FY2025 was $77.4 million, up 16.98%.
  • Other Operating Expenses for Q4 2025 was $20.8 million at Orthopediatrics, down from $20.9 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for KIDS hit a ceiling of $22.1 million in Q2 2025 and a floor of $8.9 million in Q1 2021.
  • Median Other Operating Expenses over the past 5 years was $13.9 million (2023), compared with a mean of $14.5 million.
  • Peak annual rise in Other Operating Expenses hit 93.52% in 2021, while the deepest fall reached 35.75% in 2021.
  • Orthopediatrics' Other Operating Expenses stood at $10.1 million in 2021, then grew by 18.25% to $12.0 million in 2022, then rose by 6.79% to $12.8 million in 2023, then skyrocketed by 45.47% to $18.6 million in 2024, then increased by 11.54% to $20.8 million in 2025.
  • The last three reported values for Other Operating Expenses were $20.8 million (Q4 2025), $20.9 million (Q3 2025), and $22.1 million (Q2 2025) per Business Quant data.